TMEM106C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.655800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.517640E-01
Normal-vs-Stage2
3.871200E-01
Normal-vs-Stage3
9.477200E-01
Normal-vs-Stage4
7.295400E-01
Stage1-vs-Stage2
4.309600E-01
Stage1-vs-Stage3
1.338230E-01
Stage1-vs-Stage4
2.202800E-01
Stage2-vs-Stage3
2.937400E-01
Stage2-vs-Stage4
4.841000E-01
Stage3-vs-Stage4
7.248600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.912400E-01
Normal-vs-AfricanAmerican
2.226400E-01
Normal-vs-Asian
1.611570E-01
Caucasian-vs-AfricanAmerican
9.257000E-01
Caucasian-vs-Asian
2.902400E-01
AfricanAmerican-vs-Asian
3.935600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.843640E-03
Normal-vs-Female
3.887600E-01
Male-vs-Female
6.914300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.529600E-01
Normal-vs-Age(41-60Yrs)
3.243200E-04
Normal-vs-Age(61-80Yrs)
4.890000E-01
Normal-vs-Age(81-100Yrs)
2.065200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.861800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.474400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.654800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.036140E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.317800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.469200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.907200E-01
Normal-vs-Daily Drinker
2.868000E-01
Normal-vs-Weekly Drinker
3.285400E-01
Normal-vs-Occasional Drinker
5.055600E-02
Normal-vs-Social Drinker
1.348810E-01
Non Drinker-vs-Daily Drinker
8.239400E-01
Non Drinker-vs-Weekly Drinker
9.309000E-01
Non Drinker-vs-Occasional Drinker
3.312200E-01
Non Drinker-vs-Social Drinker
5.198400E-01
Daily Drinker-vs-Weekly Drinker
9.034600E-01
Daily Drinker-vs-Occasional Drinker
4.424600E-01
Daily Drinker-vs-Social Drinker
5.873800E-01
Weekly Drinker-vs-Occasional Drinker
4.182800E-01
Weekly Drinker-vs-Social Drinker
5.567200E-01
Occasional Drinker-vs-Social Drinker
9.485000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.306200E-01
Normal-vs-Grade 2
7.659600E-01
Normal-vs-Grade 3
8.045400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.982200E-01
Grade 1-vs-Grade 3
7.206800E-01
Grade 1-vs-Grade 4
7.306200E-01
Grade 2-vs-Grade 3
8.629800E-01
Grade 2-vs-Grade 4
7.659600E-01
Grade 3-vs-Grade 4
8.045400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.537400E-01
Normal-vs-NonDiabetic
3.641000E-01
Diabetic-vs-NonDiabetic
1.252030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.606830E-01
Normal-vs-NoPancreatitis
3.990600E-01
Pancreatitis-vs-NoPancreatitis
6.086400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.003400E-01
Normal-vs-N1
4.216600E-01
N0-vs-N1
4.415200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.076710E-03
Normal-vs-TP53-NonMutant
1.303820E-03
TP53-Mutant-vs-TP53-NonMutant
8.835200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
